Match Document Document Title
9945863 Coiled coil helix cristae morphology 1 (CHCM1) tumor marker and cancer therapeutic target  
Methods for diagnosing and treating a cancer or a tumor in a patient are provided. The methods can comprise the steps of obtaining a biological sample from the patient and analyzing the sample for...
9945862 Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds  
Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof (e.g., lenvatinib mesylate). The...
9945861 Methods for predicting the survival time of a patient suffering from a solid cancer based on density of B cells  
The present invention relates to a method for predicting the survival time of a patient suffering from a solid cancer comprising the steps consisting of i) determining the density of B cells at...
9945783 Cervical cancer information providing method and device  
Provided is a canceration information providing method capable of presenting the information related to canceration of the cells with high reliability. A cell in which the amount of DNA is greater...
9944990 Gene expression markers for breast cancer prognosis  
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
9944927 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer  
The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of...
9944718 ADAM22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease  
A method of diagnosing metastatic potential of a breast cancer in an individual with breast cancer is described. The method comprises a step of assaying a breast cancer tumor sample from the...
9944709 CD123 specific chimeric antigen receptors for cancer immunotherapy  
The present invention relates to Chimeric Antigen Receptors (CAR) that are recombinant chimeric proteins able to redirect immune cell specificity and reactivity toward selected membrane antigens,...
9944702 CD33 specific chimeric antigen receptors for cancer immunotherapy  
The present invention relates to Chimeric Antigen Receptors (CAR) that are recombinant chimeric proteins able to redirect immune cell specificity and reactivity toward selected membrane antigens,...
9944701 Methods of treating cancer with antibodies that bind P2X7 receptors  
The invention relates to purinergic (P2X) receptors, to generation of antibodies and to use of antibodies and immunogens for detection and treatment of a disease or condition, especially cancer.
9944641 Isoquinolinone derivatives useful in the treatment of cancer  
The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as a drug, notably in the treatment of...
9944640 Pyrimidine-2,4-diamine derivatives for treatment of cancer  
A compound of formula I, or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
9943579 Immunotherapy against several tumors, such as lung cancer, including NSCLC  
A method of treating a patient who has non-small cell lung carcinoma (NSCLC), lung cancer, gastric cancer, and/or glioblastoma includes administering to said patient a composition containing a...
9943570 Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy  
The present invention relates to an inhibitor of Hairy and Enhancer of Split 3 (Hes3) or for use in treating a tumor. The invention further relates to an in-vitro method for diagnosing a tumor,...
9943568 Methods of using pegylated interleukin-10 for treating cancer  
Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith, are provided.
9943544 Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancer  
The present invention is a process for bio synthesis of nano arsenic trioxide defined by its low toxicity, higher bio availability and nano particle size with the aid of buttermilk, goat urine,...
9943534 Composition for preventing or treating liver cancer containing ginsenoside F2  
The present invention relates to a composition for preventing or treating liver cancer containing ginsenoside F2 as an active ingredient. Specifically, the composition according to the present...
9943505 Glucocorticoid receptor modulators to treat pancreatic cancer  
Methods and compositions for treating a subject hosting a non-ACTH-secreting pancreatic tumor are disclosed. The methods include administering to the subject a chemotherapeutic agent and a...
9943502 Lung cancer adjuvant therapy  
The present invention includes compositions and methods for the treatment of cancer comprising an antineoplastic drug and an inhibitor of chromosome maintenance region 1 (CRM1) protein expression...
9939445 Detection method for cancer cell in vitro and system using the same  
A cancer cell detection system includes a sample holder, a laser light source, a light detector, and a determine module. The sample holder holds a cell measurement component having metal...
9939442 Salivary biomarkers for gastric cancer detection  
Disclosed herein are biomarkers related to gastric cancer. The presently identified salivary biomarkers create the basis for a gastric cancer detection bioassay with sensitivity and specificity....
9938582 Recurrent gene fusions in prostate cancer  
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to...
9938561 Method for diagnosing cancer through detection of deglycosylation of glycoprotein  
Provided is a method for diagnosing cancer through a difference with a control group in view of the ratio of a deglycosylated peptide fragment and a non-glycosylated peptide fragment in a protein...
9938344 Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer  
This invention relates to humanized antibodies that selectively bind the 31.1 epitope on the A33 protein differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas...
9938265 1,3,4-thiadiazole compounds and their use in treating cancer  
A compound of Formula (I): or a pharmaceutically acceptable salt thereof, where: Q can be 5-methylpyridazin-3-yl,5-chloropyridazin-3-yl, 6-methylpyridazin-3-yl, or 6-fluoropyridazin-3-yl; R can be...
9937267 Methods of treating cancer using compounds containing a vascular disrupting agent  
The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs...
9937247 Universal cancer vaccine  
Described herein are compositions of matter and methods for treating cancer. The compositions comprise altered human telomerase polypeptides containing T cell epitopes that have been altered to...
9937227 Humanin, analogs and cancer treatment methods and uses thereof  
Described herein are methods of enhancing chemotherapeutic treatment of a hyperproliferative disorder by, in part, administering a composition comprising one or more humanin polypeptides to a...
9937226 Use of immunomodulatory protein from ganoderma in inhibiting cancer stem cells  
The present invention relates to a new use of an immunomodulatory protein derived from Ganoderma or a recombinant or a composition thereof in inhibiting cancel stem cells. Particularly, the...
9937216 Method for suppressing proliferation and/or inducing apoptosis of cancer cells  
It is to provide an agent for suppressing proliferation and/or inducing apoptosis of cancer cells that can be used for the treatment and chemoprophylaxis of cancer, wherein the agent is easily...
9937193 Method for treating a cancer  
The present invention relates to a method for treating a cancer with the combination of a topoisomerase II inhibitor (TOP2 inhibitor) and a histone deacetylation inhibitor (HDACi), provides...
9937179 Combined treatment for cancer resistant to an epidermal growth factor receptor kinase inhibitor  
The present invention provides a method for treating a cancer, comprising (a) identifying a patient with acquired resistance to an EGFR kinase inhibitor; and (b) administering to the patient an...
9937170 Treatment of cancer with TOR kinase inhibitors  
Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor...
9937169 Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy  
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound and an effective amount of an androgen receptor...
9934364 Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis  
The present disclosure provides methods for applying artificial neural networks to flow cytometry data generated from biological samples to diagnose and characterize cancer in a subject.
9932641 Fusion genes associated with progressive prostate cancer  
The present invention relates to methods and compositions for determining whether a subject having prostate cancer is at greater risk of developing progressive disease, and methods of treating the...
9932640 Clinical use of an Alu element based bioinformatics methodology for the detection and treatment of cancer  
The present invention relates generally to the field of human genetics. More specifically, this invention relates to the clinical application of a bioinformatics methodology described in patent...
9932405 Use of chimeric antigen receptor modified cells to treat cancer  
The present disclosure relates to compositions and methods for compositions, methods, and kits for treating cancer using chimeric antigen receptor (CAR) modified cells. Some embodiments of the...
9932389 Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer  
A chemoembolic agent is disclosed that includes an injectable, recombinantly synthesized silk-elastin like protein copolymer and one or more chemotherapeutic agents. Upon injection, the...
9932310 DNA2 inhibitors for cancer treatment  
Disclosed herein, inter alia, are compositions and methods for inhibiting DNA2.
9932288 Chemical compound for inhibition of SHP2 function and for use as an anti-cancer agent  
This invention provides a compound that is 4,4′-(4′-Carboxy)-4-nonyloxy-[1,1′-biphenyl]-3,5-diyl)dibuta noic acid (CNBDA), derivative compounds of CNBDA, and pharmaceutical compositions thereof....
9931416 Anti-claudin 1 antibodies for use in the treatment of colorectal cancer  
The present invention relates to anti-claudin 1 antibodies for use in the treatment of colorectal cancer. In particular, the present invention relates to a method of treating a colorectal cancer...
9931406 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant  
Disclosed is a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof and a non-metallic salt lubricant, which can be used as an effective cancer...
9931387 Cancer vaccine for cats  
The present invention provides a nucleic acid, or an immunogenic composition thereof, that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment...
9931373 Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein  
Disclosed are pharmaceutical and synergistic compositions human recombinant alpha-fetoprotein expressed in eukaryotic cells for preparation of therapeutic agents for use in oncology,...
9931359 Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancer  
The invention provides methods and compositions for administration of allogeneic lymphocytes as an exogenous source of CD4+ T cell help for endogenous, tumor-reactive CD8+ T cells. Depletion of...
9931355 Combination of compounds derived from gallic acid for the treatment of cancer  
The invention relates to a combination of compounds derived from gallic acid, with an antitumoral and antimetastatic activity via a mechanism that involves the induction of apoptosis and the...
9931342 Compositions and methods for the treatment of cancer  
The present disclosure provides compositions and methods for the treatment of cancer, relating to the specific inhibition of Abelson (ABL) kinases.
9931339 Substituted pyrrolo[2,3-b]quinoxalines for cancer therapy  
Compounds, including quinoxaline derivatives of formula I, for use in the treatment of cancer are described. In general, the compounds inhibit the import of proteins and transcription factors such...
9931331 Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients  
The present invention relates to an anticancer supplement containing loperamide as an active ingredient. More specifically, a proteasome inhibitor alone cannot exhibit an anticancer effect on...